← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alzheon, Inc.
Framingham, MA
$51,190,244
Total funding
1
Grants
Funding over time
peak $15M · FY2020–24$20M$15M$10M$5M$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$51,190,244 · 1
By mechanism
R01$51,190,244 · 1
Investigators at Alzheon, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study$15,000,000
R01 · FY2020 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study$12,500,000
R01 · FY2021 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study$11,000,000
R01 · FY2022 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study$6,500,000
R01 · FY2023 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study - COVID supplement$3,500,000
R01 · FY2022 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study$2,265,244
R01 · FY2024 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study$425,000
R01 · FY2023 · AG